BVS
Bioventus Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.62
+0.02 ▲ +0.23%
🌙 3월 13일 4:26 PM ET (한국 3/14 05:26)
$8.62
+0.00 +0.00%
| Index | RUT | P/E | 26.3 | EPS (ttm) | 0.33 | Insider Own | 31.35% | Shs Outstand | 0.07B | Perf Week | 2.5% |
| Market Cap | 0.72B | Forward P/E | 9.87 | EPS next Y | 16.41% | Insider Trans | -0.15% | Shs Float | 0.05B | Perf Month | 6.68% |
| Enterprise Value | 1.02B | PEG | 0.68 | EPS next Q | 0.1 | Inst Own | 56.8% | Short Float | 3.11% | Perf Quarter | 14.93% |
| Income | 0.02B | P/S | 1.26 | EPS this Y | 10.36% | Inst Trans | 2.07% | Short Ratio | 4.92 | Perf Half Y | 18.41% |
| Sales | 0.57B | P/B | 3.14 | EPS next 5Y | 14.43% | ROA | 3.22% | Short Interest | 1.44M | Perf YTD | 15.86% |
| Book/sh | 2.74 | P/C | 13.99 | EPS past 3/5Y | - 33.74% | ROE | 13.69% | 52W High | -14.88% ($10.13) | Perf Year | -10.3% |
| Cash/sh | 0.62 | P/FCF | 10.04 | Sales past 3/5Y | 3.52% 12.08% | ROIC | 4.77% | 52W Low | 48.36% ($5.81) | Perf 3Y | 449.04% |
| Dividend Est. | - | EV/EBITDA | 9.78 | EPS Y/Y TTM | 164.93% | Gross Margin | 67.32% | Volatility(W/M) | 3.85% 4.29% | Perf 5Y | -39.93% |
| Dividend TTM | - | EV/Sales | 1.8 | Sales Y/Y TTM | -0.91% | Oper. Margin | 10.11% | ATR (14) | 0.4 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.19 | EPS Q/Q | 8975% | Profit Margin | 4% | RSI (14) | 52.05 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.7 | Sales Q/Q | 2.77% | SMA20 | -0.43% ($8.66) | Beta | 0.73 | Target Price | $15 |
| Payout | - | Debt/Eq | 1.69 | Earnings | 3000000 | SMA50 | 4.86% ($8.22) | Rel Volume | 0.98 | Prev Close | $8.6 |
| Employees | 930 | LT Debt/Eq | 1.59 | EPS/Sales Surpr. | 11.21% 1.91% | SMA200 | 18.11% ($7.3) | Avg Volume(3M) | 0.29M | Price | $8.62 |
| IPO | 2021/2/11 | Option/Short | Yes/Yes | Trades | 4863 | Volume | 286,351 | Change | 0.23% |
뉴스 로딩 중...